Klaus Düring

Title: Innovations of Klaus Düring

Introduction

Klaus Düring is a notable inventor based in Frechen, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides with antimicrobial properties. With a total of 2 patents, his work has implications in various applications, including agriculture and medicine.

Latest Patents

Düring's latest patents include "Lysozyme-analogous polypeptides with an anti-microbial effect, their production and use." This invention focuses on polypeptides that exhibit antibiotic, anti-viral, and anti-cancer effects. Specifically, it relates to modified T4 lysozyme and polypeptides comprising fragments of T4 lysozyme, which can be utilized in human and veterinary medicine, resistance cultivation in plants, and the prevention of food spoilage caused by bacteria and fungi. Another significant patent is the "Expression system for anaerobic gene expression in higher plants." This invention presents an expression system that includes the promoter GapC4 or its variants, aimed at enhancing gene expression in higher plants, particularly for agricultural resistance cultivation.

Career Highlights

Throughout his career, Klaus Düring has worked with companies such as MPG Cologne GmbH Molecular Plant & Protein Biotechnology and MPB Cologne GmbH Molecular Plant and Protein Biotechnology. His expertise in molecular plant biotechnology has positioned him as a key figure in the development of innovative solutions in this field.

Collaborations

Düring has collaborated with notable colleagues, including Rüdiger Cerff and Reinhard Hehl. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Klaus Düring's contributions to biotechnology through his innovative patents demonstrate his commitment to advancing science and technology. His work continues to have a lasting impact on various fields, including agriculture and medicine.